EANO is Europe’s multidisciplinary Neuro-Oncology organisation representing all medical and scientific disciplines involved in the prevention, diagnosis and treatment of tumours of the central nervous system (CNS). EANO is dedicated to promote advances in Neuro-Oncology through innovative research and concerted education and training. It enhances collaboration between all relevant disciplines - Neuro-Oncology, Neurosurgery, Neuropathology, Neuroradiology, and Radiation Oncology as well as Nursing - and aims at bridging science, knowledge and practice gaps in the management of CNS malignancies.
Today, EANO has over 700 members from more than 70 countries. EANO stimulates (inter)national cooperation together with our major partner societies, the Society of Neuro-Oncology in the US (SNO) and the Asian Society of Neuro-Oncology (ASNO); together, EANO, SNO and ASNO are charter societies of the World Federation of Neuro-Oncology Societies (WFNOS).
EANO provides multiple services to its members. We organise scientific and educational webinars and meetings with 'state of the art' lectures covering the broad spectrum of all disciplines in Neuro-Oncology, including our flagship annual EANO Meeting and the quadrennial WFNOS Meeting.
Further, EANO offers exclusively to its members free access to Neuro Oncology, Neuro Oncology Practice and the Neuro Oncology Advances Journals.
EANO considers the preparation of multidisciplinary guidelines as a prime task to support the development of high quality care for brain tumour patients across Europe. The EANO Youngster Initiative is a highly active platform for exchange, networking and career support for young clinicians and scientists. We also offer high level post-graduate education through the EANO School of Neuro-Oncology launched in 2022 and strongly support increasing diversity in the Neuro-Oncology community.
EANO President (2022-2024)
The EANO website is intended for use by medical professionals only. The content is not intended for use in the diagnosis or treatment of individual conditions or as a substitute for a consultation with a medical professional. We regret that EANO is not capable of responding to individual enquiries regarding any aspect of treatment, nor can EANO provide contact details of any of its members to third parties. Further, EANO will not be held liable in any way for use of information contained on this website. For a list of different brain tumour patient organisations please refer to the IBTA (International Brain Tumour Alliance) www.theibta.org. Please note that EANO is not responsible for the content of any third-party websites.